Fulvestrant and Palbociclib as First-Line Treatment for HR+/HER2- Breast Cancer

Reshma L. Mahtani DO interview on Fulvestrant and Palbociclib as First-Line Treatment for HR+/HER2- Breast Cancer
Video originally published on PracticeUpdate.com on 10/07/2020 -- www.practiceupd...
--
Follow PracticeUpdate:
Twitter: / practiceupdate
Facebook: / practiceupdate
Instagram: / practiceupdate_elsevier
LinkedIn: / practiceupdate
Register for PracticeUpdate for free at www.practiceup...